A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer ( SEAMARK )
5 de abril de 2022
Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)
